In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products

PHASE1CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
HIV Prevention
Interventions
DRUG

Tenofovir 1% gel

DRUG

Vaginal product

Trial Locations (2)

Unknown

Dept of OBGYN and Reproductive Sciences, UCSF, San Francisco

Bronx-Lebanon Hospital Center, The Bronx

All Listed Sponsors
lead

CONRAD

OTHER

NCT01813162 - In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products | Biotech Hunter | Biotech Hunter